Arcellx, Inc. (ACLX)
64.29
-0.91
(-1.40%)
USD |
NASDAQ |
Jan 02, 12:36
Arcellx Research and Development Expense (TTM): 168.16M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.734B |
| Johnson & Johnson | 15.77B |
| Amicus Therapeutics, Inc. | 142.29M |
| Relmada Therapeutics, Inc. | 29.81M |
| Invivyd, Inc. | 46.17M |